Status:
COMPLETED
Trial of the Ovicidal Activity of Three Head Lice Products (NeutraLice Lotion®, NeutraLice Advance® and Moov Head Lice Solution®) After a Single Application
Lead Sponsor:
Altman Biomedical Consulting Pty. Ltd.
Conditions:
Head Lice
Eligibility:
All Genders
Up to 12 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to compare the ovicidal activity of three head lice treatment products. The study population will consist of Queensland primary school-aged children (Grades 1 - 7) who ha...
Detailed Description
Subjects will be examined for the presence of head louse eggs. Those subjects who have at least 20 live eggs will be randomised into one of 3 treatment groups: NeutraLice Lotion, NeutraLice Advance or...
Eligibility Criteria
Inclusion
- Male or female primary school-aged children.
- Presence of at least 20 live head lice eggs on the hair. The presence of live head lice eggs will be determined from a visual inspection of the hair.
- Parent / Guardian have given written informed consent to their child's participation in the trial.
Exclusion
- History of allergies or adverse reactions to head lice products or the components of the specific products being tested.
- Treatment with any head lice product in the 4 weeks prior to participation in this trial.
- Treatment with hair dyes and bleaches within 4 weeks prior to participation in this trial.
- Presence of scalp disease(s).
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2009
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT00995124
Start Date
October 1 2009
End Date
December 1 2009
Last Update
July 28 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assoc. Prof. Stephen Barker
Brisbane, New South Wales, Australia, 4072